IBM Connections up to 3.0.1.1/4.0/4.5/5.0 CR3 cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.6 | $0-$5k | 0.00 |
Summary
A vulnerability marked as problematic has been reported in IBM Connections up to 3.0.1.1/4.0/4.5/5.0 CR3. Affected by this issue is some unknown functionality. The manipulation leads to cross site scripting. This vulnerability is uniquely identified as CVE-2015-7460. The attack is possible to be carried out remotely. No exploit exists. Applying a patch is the recommended action to fix this issue.
Details
A vulnerability, which was classified as problematic, has been found in IBM Connections up to 3.0.1.1/4.0/4.5/5.0 CR3 (Groupware Software). This issue affects an unknown code. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. The summary by CVE is:
Cross-site scripting (XSS) vulnerability in IBM Connections 3.0.1.1 and earlier, 4.0, 4.5, and 5.0 before CR4 allows remote attackers to inject arbitrary web script or HTML via unspecified vectors. IBM X-Force ID: 108356.
The bug was discovered 04/14/2016. The weakness was disclosed 03/20/2018 (Website). The advisory is shared at exchange.xforce.ibmcloud.com. The identification of this vulnerability is CVE-2015-7460 since 09/29/2015. The attack may be initiated remotely. A simple authentication is needed for exploitation. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
The vulnerability was handled as a non-public zero-day exploit for at least 705 days. During that time the estimated underground price was around $5k-$25k.
Applying the patch 5.0 CR4 is able to eliminate this problem.
The entries VDB-114795, VDB-114796 and VDB-114798 are pretty similar. If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.8VulDB Meta Temp Score: 4.7
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 5.4
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: PatchStatus: 🔍
0-Day Time: 🔍
Patch: 5.0 CR4
Timeline
09/29/2015 🔍04/14/2016 🔍
03/20/2018 🔍
03/20/2018 🔍
03/21/2018 🔍
02/05/2021 🔍
Sources
Vendor: ibm.comAdvisory: exchange.xforce.ibmcloud.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2015-7460 (🔍)
GCVE (CVE): GCVE-0-2015-7460
GCVE (VulDB): GCVE-100-114797
X-Force: 108356
See also: 🔍
Entry
Created: 03/21/2018 07:34Updated: 02/05/2021 14:52
Changes: 03/21/2018 07:34 (61), 01/15/2020 08:29 (1), 02/05/2021 14:52 (2)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.